This brand name is authorized in Japan
The drug BISULASE contains one active pharmaceutical ingredient (API):
|
1
Riboflavin
UNII 957E53WV42 - RIBOFLAVIN 5'-PHOSPHATE SODIUM ANHYDROUS
|
|
Riboflavine is phosphorylated to flavine mononucleotide and flavine adenine dinucleotide which act as co-enzymes in the respiratory chain and in oxidative phosphorylation. Riboflavine deficiency presents with ocular symptoms, as well as lesions on the lips and at angles of the mouth. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A11HA04 | Riboflavin (vit B2) | A Alimentary tract and metabolism → A11 Vitamins → A11H Other plain vitamin preparations → A11HA Other plain vitamin preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3131401A3032, 3131401A4020 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
